Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Clear all

684 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200113
200218
200336
200434
200530
200655
200747
200837
200939
201040
201138
201233
201334
201433
20159
201628
201730
201813
201914
202011
20218
202217
20239
20246
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed530
Terminated73
Unknown status42
Active, not recruiting12
Recruiting10
Withdrawn8
Not yet recruiting5
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S182
AstraZeneca49
Takeda40
Eli Lilly and Company24
Sanofi12
GlaxoSmithKline11
Pfizer11
Astellas Pharma Inc9
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8
National Heart, Lung, and Blood Institute (NHLBI)7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus684
Diabetes Mellitus, Type 2333
Diabetes Mellitus, Type 188
Glucose Metabolism Disorders47
Insulin Resistance39
Hypertension35
Dyslipidemias33
Obesity26
Cardiovascular Diseases25
Metabolic Diseases23

Trials

Showing 51 to 75 of 684. Each trial links to its page on Pharma Observatory.

584 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.